Ocuphire Pharma Investor Updates slide image

Ocuphire Pharma Investor Updates

P 13 Baseline Characteristics Study Eye (PP Population) Treatment Arms Were Balanced Across Key Ocular Measurements Baseline Characteristic Photopic DCNVA Mean Letters read-Binocular (Snellen Equiv.) 70 letters = 20/20 Photopic BCDVA Mean Letters read-Binocular (Snellen Equiv.) 55 letters = 20/20 Photopic Pupil Diameter Mean (mm) Mesopic Pupil Diameter Mean (mm) IOP (mmHg) Placebo Alone N=43 46 (20/63) 62 (20/15) 4.3 5.1 13.5 Nyxol Alone N=30 45 (20/63) 61 (20/15) 4.5 5.0 14.8 LDP Alone N=31 48 (20/63) 60 (20/15) 4.3 5.0 13.9 Source: VEGA-1 TLR Table 14.1.2.2 Demographics and Baseline Characteristics (PP population). Snellen Conversion Chart. Nyxol+LDP N=43 46 (20/63) 61 (20/15) 4.3 5.1 14.4 Total N=147 46 (20/63) 61 (20/15) 4.3 5.1 14.1 Ocuphire PHARMA
View entire presentation